Operational and policy considerations of data monitoring in clinical trials:: The diabetes control and complications trial experience
- 28 February 1993
- journal article
- clinical trial
- Published by Elsevier in Controlled Clinical Trials
- Vol. 14 (1) , 30-44
- https://doi.org/10.1016/0197-2456(93)90048-i
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Data monitoring committees for multicenter clinical trials sponsored by the national institutes of health: I. Roles and membership of data monitoring committees for trials sponsored by the national eye instituteControlled Clinical Trials, 1991
- Interim analysis in clinical trialsStatistics in Medicine, 1991
- Diabetes Control and Complications Trial (DCCT): Results of Feasibility Study. The DCCT Research GroupDiabetes Care, 1987
- The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research GroupDiabetes, 1986
- Assessing possible late treatment effectsin stopping a clinical trial early: A case study. Diabetic retinopathy study report no. 9Controlled Clinical Trials, 1984
- Statistical aspects of early termination in the beta-blocker heart attack trialControlled Clinical Trials, 1984
- A case report of data monitoring experience: The nocturnal oxygen therapy trialControlled Clinical Trials, 1982
- Factors influencing the interim interpretation of a breast cancer trial: Danger of achieving the “expected” resultControlled Clinical Trials, 1981
- Practical aspects of decision making in clinical trials: The coronary drug project as a case studyControlled Clinical Trials, 1981
- Influence of Adherence to Treatment and Response of Cholesterol on Mortality in the Coronary Drug ProjectNew England Journal of Medicine, 1980